tisseel kit
baxter healthcare limited - factor i (fibrinogen) plasmafibronectin factor xiii profibrinolysin aprotinin thrombin protein thrombin protein calcium chloride dihydrate - cutaneous solution - 0.5ml millilitre
tisseel kit
baxter healthcare limited - factor i (fibrinogen) plasmafibronectin factor xiii profibrinolysin aprotinin thrombin protein thrombin protein calcium chloride dihydrate - unknown - 1.0ml millilitre
tisseel kit
baxter healthcare limited - factor i (fibrinogen) plasmafibronectin factor xiii profibrinolysin aprotinin thrombin protein thrombin protein calcium chloride dihydrate - cutaneous solution - 2.0ml millilitre
tisseel kit
baxter healthcare limited - factor i (fibrinogen) plasmafibronectin factor viii, human profibrinolysin aprotinin thrombin protein thrombin protein calcium chloride dihydrate - unknown - 5.0ml millilitre
actilyse cathflo 2 mg inj./inf. sol. (pwdr.) i.v. vial
boehringer ingelheim scomm-commv - alteplase 2 mg - powder for solution for injection/infusion - 2 mg - alteplase 2 mg - fibrinolysin
cyklokapron solution for injection 500mg/5ml mg/5ml
pharmacia ireland - tranexamic acid - solution for injection - 500mg/5ml mg/5ml
amicar aminocaproic acid tablet
avera mckennan hospital - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid 500 mg
aminocaproic acid injection, solution
american regent, inc. - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid 250 mg in 1 ml - aminocaproic acid injection is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. in life-threatening situations, fresh whole blood transfusions, fibrinogen infusions, and other emergency measures may be required. fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures), and portacaval shunt; hematological disorders such as aplastic anemia; acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. urinary fibrinolysis, usually a normal physiological phenomenon, may frequently be associated with life-threatening complications following severe trauma, anoxia, and shock. symptomatic of such complications is surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system). (see warnings.) aminocaproic acid should
aminocaproic acid injection, solution
hospira, inc. - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid 250 mg in 1 ml - aminocaproic acid injection, is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. in life-threatening situations, fresh whole blood transfusions, fibrinogen infusions, and other emergency measures may be required. fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures), and portacaval shunt; hematological disorders such as aplastic anemia; acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. urinary fibrinolysis, usually a normal physiological phenomenon, may frequently be associated with life-threatening complications following severe trauma, anoxia, and shock. symptomatic of such complications is surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system). (see warnings .) aminocaproic acid shoul
amicar- aminocaproic acid solution amicar- aminocaproic acid tablet
akorn operating company llc - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid 0.25 g in 1 ml - amicar is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. in life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required. fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. urinary fibrinolysis, usually a normal physiological phenomenon, may contribute to excessive urinary tract fibrinolytic bleeding associated with surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system). (see warnings .) amicar should not be used when there is evidence of an active intravascular c